Effect observation of low dose of docetaxel and cisplatin combined with radiotherapy on the elderly patients with esophageal cancer
10.3760/cma.j.issn.1006-9801.2015.10.009
- VernacularTitle:小剂量TP方案同步放化疗治疗老年人局部晚期食管癌效果观察
- Author:
Ruihua FAN
;
Tiecheng ZHANG
;
Rong YAO
;
Mingde HUANG
- Publication Type:Journal Article
- Keywords:
Esophageal neoplasms;
Docetaxel;
Cisplatin;
Radiotherapy;
Elderly
- From:
Cancer Research and Clinic
2015;27(10):683-686
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the efficacy and toxicity of low dose of docetaxel and cisplatin (TP) combined with radiotherapy in the treatment of elderly patients with esophageal cancer.Methods The data of 65 elderly patients with esophageal cancer were studied retrospectively, including 33 patients treated by TP combined with radiotherapy (chemoradiotherapy group) and 32 patients by radiotherapy only (radiotherapy group).Patients in both groups received 3D conventional radiotherapy (3D-CRT).In chemoradiotherapy group, 40 mg/1f docetaxel and 40 mg/1f cisplatin were administered once a week on the 1st, 8th, 15th, 22th, 36th day of five successive weeks.Results In chemoradiotherapy group and radiotherapy group, the response (CR+RR) rates were 87.8 ％ (29/33) and 65.6 ％ (21/32), respectively (P ＜ 0.05), the median TTPs were 5.5 months and 4.3 months, and the difference had statistically significant (P ＜ 0.05).The 1-year survival rate was 69.6 ％ and 59.3 ％ in chemoradiotherapy group and radiotherapy group, respectively, and there was no statistically significant difference between both groups (P ＞ 0.05).The incidences of esophagitis and gastrointestinal tract were slightly higher in chemoradiotherapy group than those in radiotherapy group (P ＜ 0.05).Conclusion Concurrent radiotherapy and chemotherapy with low dose TP can treat effectively esophageal cancer in elderly patients with the tolerable toxic reactions.
